Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2146500
Max Phase: Preclinical
Molecular Formula: C30H42N6O2S
Molecular Weight: 550.77
Molecule Type: Small molecule
Associated Items:
ID: ALA2146500
Max Phase: Preclinical
Molecular Formula: C30H42N6O2S
Molecular Weight: 550.77
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCN(CC[C@H]1CC[C@H](NC(=O)c2ccc(-c3noc(C(C)C)n3)cc2)CC1)[C@H]1CCc2nc(N)sc2C1
Standard InChI: InChI=1S/C30H42N6O2S/c1-4-16-36(24-13-14-25-26(18-24)39-30(31)33-25)17-15-20-5-11-23(12-6-20)32-28(37)22-9-7-21(8-10-22)27-34-29(19(2)3)38-35-27/h7-10,19-20,23-24H,4-6,11-18H2,1-3H3,(H2,31,33)(H,32,37)/t20-,23-,24-/m0/s1
Standard InChI Key: KFPBHSIVRJWDRK-OYDLWJJNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 550.77 | Molecular Weight (Monoisotopic): 550.3090 | AlogP: 5.85 | #Rotatable Bonds: 10 |
Polar Surface Area: 110.17 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 8 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 10.66 | CX LogP: 6.22 | CX LogD: 3.11 |
Aromatic Rings: 3 | Heavy Atoms: 39 | QED Weighted: 0.33 | Np Likeness Score: -1.59 |
1. Chen J, Levant B, Wang S.. (2012) High-affinity and selective dopamine D₃ receptor full agonists., 22 (17): [PMID:22871578] [10.1016/j.bmcl.2012.07.003] |
Source(1):